TALIS BIOMEDICAL CORPORATION AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • January 6th, 2021 • Talis Biomedical Corp • Laboratory analytical instruments • Delaware
Contract Type FiledJanuary 6th, 2021 Company Industry JurisdictionTHIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the “Agreement”) is entered into as of the 30th day of October, 2020, by and among TALIS BIOMEDICAL CORPORATION, a Delaware corporation (the “Company”) and the investors listed on Exhibit A hereto, referred to hereinafter as the “Investors” and each individually as an “Investor.”